Kathryn Richmond directs the overall research portfolio strategy and all grant programs at The Paul G. Allen Frontiers Group, overseeing ~$200M in award funding. In addition, she frequently serves as a reviewer with federal agencies and partner organizations for multidisciplinary 'frontier' research programs, and as an invited panel member on topics ranging from science philanthropy to technology development. Since joining the organization in 2012, Richmond has grown the bioscience portfolio, expanded the Allen Distinguished Investigator program and led funding in emerging bioscience and technology areas. She previously served as Director of Enabling Technologies at the Great Lakes Bioenergy Research Center. In that position, she developed and oversaw a diverse portfolio of numerous technologies ranging from "omics" to plant transformation which supported the research needs of its 300 members. Prior to that, Richmond worked as a bench scientist, project lead and industry consultant, garnering two patents and multiple publications. Along with a doctorate in Cell and Molecular Biology from the University of Wisconsin, Madison, Richmond also holds an MBA and attended Stanford University as an American Cancer Society fellow.